CLINICAL_TRIALS
research
· 2024-09-25
Clinical Trial Update: Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD [Phase 2, Phase 3]
Summary
Clinical trial update describes a Chinese medicine Yi-Qi-Qing-Jie Herbal Compound combined with immunosuppressants being studied in IgA nephropathy patients at …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: IgA Nephropathy at High Risk of Developing ESRD | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING